Invesco’s NantHealth, Inc NH Stock Holding History

Invesco’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,637	Closed	-$79K	–	4076
2021 Q1	$79K	Buy	1,637 +49	+3%	+$2.84K	﹤0.01%	3789
2020 Q4	$77K	Buy	+1,588	New	+$59.7K	﹤0.01%	3679

Other funds holding NH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco's NH Position: Q2 2021 in Review

Invesco sold out of NantHealth, Inc (NH) in Q2 2021, closing a stake of 1,637 shares — an estimated $79K sold.

Invesco first reported a position in NH in Q4 2020 and held it in 2 quarters. The position peaked at $79K in Q1 2021. 45 funds tracked by Wall St. Rank hold NH as of Q2 2021.

Invesco reported no remaining NantHealth, Inc position as of Q2 2021 after selling out during the quarter.
Invesco sold 1,637 NantHealth, Inc shares in Q2 2021, an estimated $79K.
Invesco first reported a position in NantHealth, Inc in Q4 2020 and held it in 2 quarters.
Invesco's NantHealth, Inc position peaked at $79K in Q1 2021.
45 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2021.

Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.